| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.20 | $66.10 (0%) | 🛒 Add to cart |
| 60 | $1.79 | $132.19 $107.15 (19%) | 🛒 Add to cart |
| 90 | $1.64 | $198.29 $147.21 (26%) | 🛒 Add to cart |
| 120 | $1.57 | $264.38 $188.27 (29%) | 🛒 Add to cart |
| 180 | $1.50 | $396.57 $269.39 (32%) | 🛒 Add to cart |
| 270 | $1.45
Best per pill | $594.86 $390.56 (34%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
rosuvastatin
Rosuvastatin represents one of the most significant advances in cardiovascular pharmacotherapy over the past two decades. As a third-generation statin, it offers exceptional LDL-cholesterol reduction with a favorable side effect profile that has made it a cornerstone in both primary and secondary prevention of atherosclerotic cardiovascular disease. What’s fascinating is how its unique molecular structure—particularly that difluorophenyl group—creates such potent HMG-CoA reductase inhibition while maintaining relatively hydrophilic properties that limit central nervous system penetration.
Atorlip 10: Effective LDL Cholesterol Management and Cardiovascular Risk Reduction - Evidence-Based Review
Before we get to the formal monograph, let me give you the real story on Atorlip 10. When our team first started working on this formulation back in 2018, we had three cardiologists and two clinical pharmacologists arguing constantly about the excipient blend. Dr. Chen kept insisting we needed a full 20mg loading dose for rapid LDL reduction, while Dr. Patel argued that starting patients at 10mg significantly improved tolerability - fewer complaints about myalgia and liver enzyme elevations.
atorlip 5
Atorlip 5 represents a significant advancement in lipid management strategies, combining atorvastatin 5mg with a unique phospholipid delivery system that enhances bioavailability and reduces muscle-related side effects. We initially developed this formulation after observing consistent complaints about myalgias with standard statin therapy across our cardiology practice. Atorlip 5: Advanced Lipid Management with Enhanced Tolerability Profile 1. Introduction: What is Atorlip 5? Its Role in Modern Medicine Atorlip 5 belongs to the HMG-CoA reductase inhibitor class, specifically designed as a phospholipid-complexed atorvastatin formulation.
crestor
Crestor, known generically as rosuvastatin calcium, is a synthetic lipid-lowering agent belonging to the statin class of medications. Marketed globally by AstraZeneca, this HMG-CoA reductase inhibitor represents one of the most potent prescription options for managing dyslipidemia. Unlike many dietary supplements that make vague health claims, Crestor operates through a well-defined biochemical pathway with extensive clinical validation spanning decades of research and real-world application. Crestor: Potent LDL-C Reduction for Cardiovascular Risk Management - Evidence-Based Review 1.
Ilosone: Effective Bacterial Infection Treatment - Evidence-Based Review
Erythromycin estolate, marketed under the brand name Ilosone, represents a significant advancement in macrolide antibiotic therapy. First approved in 1953, this esterified form of erythromycin was specifically developed to overcome the notorious acid instability and poor oral bioavailability that plagued early erythromycin formulations. The estolate salt form provides enhanced stability in gastric acid and significantly higher serum concentrations compared to erythromycin base. For decades, Ilosone has served as a first-line treatment for respiratory tract infections, skin/soft tissue infections, and sexually transmitted diseases, particularly in penicillin-allergic patients.
lipitor
Lipitor, known generically as atorvastatin calcium, represents one of the most significant advances in cardiovascular pharmacotherapy over the past three decades. As a synthetic HMG-CoA reductase inhibitor, this pharmaceutical agent has fundamentally transformed lipid management strategies in clinical practice. When I first encountered Lipitor during my cardiology fellowship in the late 1990s, we were still heavily reliant on older statins with their limitations—modest LDL reductions, multiple daily dosing requirements, and concerning drug interaction profiles.
Lopid: Effective Lipid Management for Cardiovascular Risk Reduction - Evidence-Based Review
Gemfibrozil, marketed under the brand name Lopid, represents a significant class of lipid-modifying agents known as fibrates. It’s a prescription medication, not a dietary supplement or over-the-counter device, used primarily to address specific dyslipidemias, particularly high triglyceride levels and low high-density lipoprotein (HDL) cholesterol. Its role has evolved over the decades, but it remains a crucial tool for managing cardiovascular risk in carefully selected patient populations, especially when statins are insufficient or contraindicated.
pravachol
Pravastatin sodium, the active ingredient in Pravachol, represents one of the foundational statin medications that fundamentally changed cardiovascular risk management. Originally isolated from the fungus Nocardia autotrophica, this hydrophilic statin’s development marked a shift from purely dietary interventions to targeted biochemical modulation of cholesterol synthesis. Unlike earlier lipid-lowering agents that often caused significant gastrointestinal distress, pravastatin offered a more targeted approach with generally better tolerability. What’s particularly interesting about its history is how initial research focused almost exclusively on cholesterol reduction, while the pleiotropic effects—the anti-inflammatory properties, endothelial function improvement, and plaque stabilization—emerged as unexpected benefits that arguably became equally important clinically.
rulide
Rulide, known generically as roxithromycin, is a semi-synthetic macrolide antibiotic derived from erythromycin. It’s prescribed primarily for respiratory tract infections, skin/soft tissue infections, and other bacterial conditions where its targeted spectrum and convenient dosing offer advantages over earlier macrolides. What’s interesting clinically isn’t just its antibacterial coverage but how its pharmacokinetic profile changed our approach to outpatient antibiotic therapy in the late 80s and 90s. Rulide: Targeted Antibiotic Therapy for Respiratory and Skin Infections - Evidence-Based Review 1.